Viimeisimmät kokeilut

EudraCT Number: 2021-000214-42 Sponsor Protocol Number: 755-201-EB Start Date:
Sponsor Name: InMed Pharmaceuticals Inc.
Full Title: A Randomised, Double-Blind, Vehicle-Controlled Phase 2 Study of Topically Applied INM-755 (cannabinol) Cream in Patients with Epidermolysis Bullosa.
Medical condition: Epidermolysis bullosa
Disease: Version SOC Term Classification Code Term Level
20.0 10010331 - Congenital, familial and genetic disorders 10014989 Epidermolysis bullosa PT
Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
Trial protocol: DE (Completed) FR (Completed) AT (Completed) GR (Ongoing) IT (Ongoing) ES (Ongoing)
Trial results: (No results available)
EudraCT Number: 2022-001624-14 Sponsor Protocol Number: LE3301 Start Date:
Sponsor Name: Pharming Technologies B.V.
Full Title: An Open-Label, Single Arm Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of Leniolisib in Pediatric Patients (Aged 4 to 11 Years) With APDS (Activated Phosphoinositide 3-Kina...
Medical condition: Activated Phosphoinositide 3-Kinase Delta Syndrome
Disease: Version SOC Term Classification Code Term Level
20.0 10010331 - Congenital, familial and genetic disorders 10078281 Activated PI3 kinase delta syndrome PT
Population Age: Children, Under 18 Gender: Male, Female
Trial protocol: FR (Ongoing) NL (Ongoing)
Trial results: (No results available)
EudraCT Number: 2004-004988-30 Sponsor Protocol Number: 23386753 Start Date:
Sponsor Name: Mater Misercordiae Hospital - Department of Anaesthesia
Full Title: PHARMACOKINETICS AND ANALGESIC EFFICACY OF LAEVOBUPIVACAINE, FENTANYL AND CLONIDINE FOR POSTOPERATIVE PARAVERTEBRAL ANAESTHESIA.
Medical condition: We are aiming to provide postoperative analgesia for breast surgery
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Female
Trial protocol: IE (Ongoing)
Trial results: (No results available)
EudraCT Number: 2009-017347-33 Sponsor Protocol Number: Clofarabine Start Date:
Sponsor Name: University of Leipzig
Full Title: A multicenter Phase I/II trial investigating the safety and efficacy (CR rate and OS) of low dose AraC with Clofarabine in patients ≥60 years with AML not eligible for conventional Chemotherapy
Medical condition: Acute myeloid leukaemia
Disease: Version SOC Term Classification Code Term Level
12.1 10000880 Acute myeloid leukaemia PT
12.1 10000880 Acute myeloid leukaemia LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: DE (Prematurely Ended)
Trial results: View results
EudraCT Number: 2011-002652-14 Sponsor Protocol Number: 701003.01.010 Start Date:
Sponsor Name: Dr. Willmar Schwabe GmbH & Co. KG
Full Title: Safety and tolerability of Pelargonium sidoides extract EPs®7630 in children (1 to 5 years old) suffering from acute bronchitis
Medical condition: Acute bronchitis
Disease: Version SOC Term Classification Code Term Level
14.1 100000004862 10000687 Acute bronchitis LLT
Population Age: Infants and toddlers, Children, Under 18 Gender: Male, Female
Trial protocol: DE (Completed)
Trial results: View results
EudraCT Number: 2009-017319-13 Sponsor Protocol Number: C-09-033 Start Date:
Sponsor Name: Alcon Research Ltd.
Full Title: Safety and Efficacy Evaluation of Topical Moxidex Otic Solution in the Treatment of Acute Otitis Media with Otorrhea in Tympanostomy Tubes
Medical condition: Acute otitis media with otorrhea in tympanostomy tubes
Disease: Version SOC Term Classification Code Term Level
12.1 10033079 Otitis media acute LLT
Population Age: Infants and toddlers, Children, Adolescents, Under 18 Gender: Male, Female
Trial protocol: FR (Ongoing) BE (Completed) FI (Prematurely Ended) DK (Prematurely Ended)
Trial results: View results
EudraCT Number: 2008-001560-37 Sponsor Protocol Number: GEM-658-EBE-0024-I Start Date:
Sponsor Name: Medizinische Fakultät der TU-München, vertreten durch den Dekan
Full Title: Sequentielle Kombination einer Chemotherapie mit Gemcitabine/Oxaliplatin und photodynamischen Therapie beim fortgeschrittenen Gallengangskarzinom
Medical condition: - advanced cholangiocarcinoma
Disease: Version SOC Term Classification Code Term Level
9.1 10008594 Cholangiocarcinoma non-resectable LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: DE (Completed)
Trial results: View results
EudraCT Number: 2014-005391-29 Sponsor Protocol Number: 2021/2014 Start Date:
Sponsor Name: Medical University of Vienna
Full Title: Effects of mannitol on delayed graft function after cadaveric renal transplantation
Medical condition: Kidney transplantation
Disease: Version SOC Term Classification Code Term Level
Population Age: Gender: Male, Female
Trial protocol: AT (Completed)
Trial results: (No results available)
EudraCT Number: 2005-005197-78 Sponsor Protocol Number: 1 Start Date:
Sponsor Name: Queen's Medical Centre, Nottingham, University Hospital NHS Trust,
Full Title: A multi-centre, randomised, parallel group, cross-over study comparing the efficacy and safety of double versus multiple injections of Botulinum Toxin type-A (Dysport®), into the gastrocnemius musc...
Medical condition: Spasticity of the Gastrocnemius Muscle due to Cerebral Palsy
Disease: Version SOC Term Classification Code Term Level
8.0 10024132 LLT
Population Age: Children, Adolescents, Under 18 Gender: Male, Female
Trial protocol: GB (GB - no longer in EU/EEA)
Trial results: (No results available)
EudraCT Number: 2018-003281-14 Sponsor Protocol Number: FCR173011/ResToP Start Date:
Sponsor Name: Fundación CRIS contra el Cáncer
Full Title: Multicenter, Open-Label, Single Arm, Phase II Exploratory Study to Evaluate the Reinduction and second stop of TKI with Ponatinib in CML in Molecular Response (ResToP)
Medical condition: Chronic myelogenous leukemia
Disease: Version SOC Term Classification Code Term Level
21.0 100000004864 10009012 Chronic myelogenous leukemia LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: ES (Ongoing)
Trial results: (No results available)

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa